1. Pink Sheet
  2. >>Product Reviews
  3. >>Approvals

2021 Saw India Enable Accelerated Regulatory Pathways – Can It Become The Norm?

 
• By Anju Ghangurde

India saw a raft of vaccine and drug approvals in 2021, backed by pandemic-related accelerated regulatory processes, and outlined its intent to step up biopharma innovation in the country.  Pharma wants some of the regulatory flexibility to stay, though experts are seeking increased transparency in the overall approach.

Time-accelerate
India Accelerated Regulatory Processs In 2021 • Source: Alamy

The pandemic forced many countries to look at regulatory science and processes differently and also put the spotlight on the powerful role of biopharma R&D and innovation in tackling global emergencies when the ecosystem works cohesively.

India, for one, took certain decisive steps in 2021 on both the regulatory front

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Product Reviews